Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
RenovoRx, Inc. - Common Stock
(NQ:
RNXT
)
1.020
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 16, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about RenovoRx, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
RenovoRx Reports Initial Results From Targeted Treatment For Pancreatic Cancer
↗
January 18, 2023
Via
Benzinga
RenovoRx Announces Initial Results in Pharmacokinetic (PK) Substudy: Data on RenovoGem™ Supports Potential for RenovoTAMP® Therapy Platform to Increase Local Gemcitabine (Chemotherapy) Delivery and Decrease Side Effects of Pancreatic Cancer Treatment
January 18, 2023
From
RenovoRx, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
January 18, 2023
Via
Benzinga
RenovoRx Strengthens Intellectual Property (IP) Portfolio with Eighth US Patent
January 05, 2023
From
RenovoRx, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Wednesday
↗
May 11, 2022
On Wednesday, 807 companies reached new 52-week lows.
Via
Benzinga
Why Adobe Shares Are Trading Higher; Here Are 31 Stocks Moving Premarket
↗
December 16, 2022
Gainers Minim, Inc. (NASDAQ: MINM) shares rose 66.5% to $0.2903 in pre-market trading after gaining over 10% on Thursday. Minim, last month, reported worse-than-expected results.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
↗
December 16, 2022
We're starting off the final trading day this week with a look at the biggest pre-market stock movers to watch for Friday!
Via
InvestorPlace
RenovoRx Announces Acceptance of Four Clinical Data Abstracts at the 2023 ASCO Gastrointestinal Cancers (ASCO GI) Symposium
December 15, 2022
From
RenovoRx, Inc.
Via
Business Wire
RenovoRx Announces Presentations at the Advanced Interventional Management Symposium (AIMsymposium) Highlighting its Innovative RenovoTAMP® Therapy Platform for Targeted Treatment of Cancers
November 17, 2022
From
RenovoRx, Inc.
Via
Business Wire
RenovoRx Reports Third Quarter 2022 Financial Results
November 14, 2022
From
RenovoRx, Inc.
Via
Business Wire
RenovoRx to Participate in ROTH Capital Deep Dive Webinar on October 27, 2022 at 1:00 P.M. ET
October 21, 2022
From
RenovoRx, Inc.
Via
Business Wire
RenovoRx to Participate in Upcoming October 2022 Investor Conferences
October 04, 2022
From
RenovoRx, Inc.
Via
Business Wire
RenovoRx Announces Presentation at Symposium on Clinical Interventional Oncology (CIO) Highlighting its Innovative Therapy Platform for Targeted Treatment of Pancreatic Cancer
September 28, 2022
From
RenovoRx, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's Intraday Session
↗
September 23, 2022
Gainers
Via
Benzinga
Why LAVA Therapeutics Shares Are Trading Higher By 97%, Here Are 49 Stocks Moving In Monday's Mid-Day Session
↗
September 26, 2022
Gainers
Via
Benzinga
RenovoRx Appoints Angela Gill Nelms as Chief Operating Officer
September 19, 2022
From
RenovoRx, Inc.
Via
Business Wire
RenovoRx to Participate in the H.C. Wainwright 24th Annual Global Investment Conference, September 12-14, 2022
September 07, 2022
From
RenovoRx, Inc.
Via
Business Wire
Why NanoVibronix Shares Surged Over 25%; Here Are 82 Biggest Movers From Friday
↗
September 26, 2022
Gainers Golden Sun Education Group Limited (NASDAQ: GSUN) shares surged 92.1% to settle at $52.89 on Friday.
Via
Benzinga
Why Adobe Is Trading Lower By 17%, Here Are 49 Stocks Moving In Thursday's Mid-Day Session
↗
September 15, 2022
Gainers HeartBeam, Inc. (NASDAQ: BEAT) shares surged 58% to $1.96 after the company announced its patent for a 12-lead electrocardiogram patch monitor intended for detection of acute coronary syndrome...
Via
Benzinga
RenovoRx Reports Second Quarter 2022 Financial Results
August 15, 2022
From
RenovoRx, Inc.
Via
Business Wire
Why Immunocore Shares Dipped 22%; Here Are 73 Biggest Movers From Friday
↗
September 12, 2022
Gainers Digital Media Solutions, Inc. (NYSE: DMS) shares climbed 71.9% to close at $2.20 on Friday after the company received a non-binding go-private proposal from Prism Data for $2.50 per share in...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
August 09, 2022
Via
Benzinga
Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday
↗
August 10, 2022
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method.
Via
Benzinga
RenovoRx Appoints James Ahlers as Chief Financial Officer
July 19, 2022
From
RenovoRx, Inc.
Via
Business Wire
RenovoRx Launches “The RenovoRx Story” Video Series
July 13, 2022
From
RenovoRx, Inc.
Via
Business Wire
RenovoRx and TIGeR-PaC Leadership to Host RenovoTAMP™ Webinar on June 21, 2022
June 09, 2022
From
RenovoRx, Inc.
Via
Business Wire
RenovoRx to Participate in the University of Cambridge’s Academy of Therapeutic Sciences Gateway to Translation Seminar Series on June 8, 2022
June 02, 2022
From
RenovoRx, Inc.
Via
Business Wire
RenovoRx to Present Preclinical Research Data Demonstrating its Innovative Therapy Platform’s Potential Utility for the Treatment of Bile Duct Cancer
May 19, 2022
From
RenovoRx, Inc.
Via
Business Wire
RenovoRx to Participate in Upcoming H.C Wainwright Global Investment Conference in May 2022
May 18, 2022
From
RenovoRx, Inc.
Via
Business Wire
RenovoRx Reports First Quarter 2022 Financial Results
May 16, 2022
From
RenovoRx, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today